Published Manuscripts Based in the STS/ACC TVT Registry

Similar documents
Published Manuscripts Based in the STS/ACC TVT Registry

Published Manuscripts Based in the STS/ACC TVT Registry

In Process, Unpublished STS/ACC TVT Registry Manuscripts

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and

In Process, Unpublished STS/ACC TVT Registry Manuscripts

Indication, Timing, Assessment and Update on TAVI

Using STS/ACC TVT Registry Data for Quality Improvement (QI) Learning Objectives. Overview 3/12/2014

One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry

Transcatheter Aortic Valve Replacement

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

TAVR: Intermediate Risk Patients

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

Evolving and Expanding Indications for TAVR

Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S.

Transcatheter heart valve thrombosis

Valve Disease. Valve Surgery. In 2015, Cleveland Clinic surgeons performed 2943 valve surgeries.

Aortic Stenosis: Open vs TAVR vs Nothing

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

Surgical aortic valve replacement (SAVR)

Is Stroke Frequency Declining?

TAVR: Review of the Robust Data from Randomized Trials

CARDIOLOGY GRAND ROUNDS

National Cardiovascular Data Registry

Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.

Transcatheter Valve Replacement: Current State in 2017

TAVR IN INTERMEDIATE-RISK PATIENTS

Aortic Stenosis: Background

Supplementary Online Content

ACTION REGISTRY New Old ID# ID #

Transcatheter Valve Therapy Registry Is A Model For Medical Device Innovation And Surveillance

The SAPIEN 3 TAVI Advantage

Incidence, Predictors, and Outcomes of Prosthesis-Patient Mismatch in 62,125 TAVR Patients. An STS/ACC TVT Registry Report

Research Article. Open Access. Rajkumar Doshi 1, Vaibhav Patel 1, Priyank Shah 2. 1 Introduction

Transcatheter aortic valve replacement with the SAPIEN 3 valve: preparing the field for the final expansion

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients:

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients

Trend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience

PARTNER 2A & SAPIEN 3: TAVI for intermediate risk patients

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Transcatheter versus Surgical Aortic Valve Replacement: A Propensity-Matched Analysis from Two United States Registries

Transcatheter procedures of the future; expanding the treatment options for patients with severe aortic stenosis

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion

The Silver Book : Valve Disease

Background: What is the cost of an aortic valve replacement?

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

TAVI limitations for low risk patients

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

2/28/2013. NCDR.13 Workshop 19

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack

Strokes After TAVR Reasons for Declining Frequency

Interventional solutions for atrial fibrillation in patients with heart failure

Valvular Intervention

Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses

Le TAVI pour tout le monde?

Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS

Strokes After TAVR. Ioannis Iakovou, MD, PhD. Interventional Cardiology Onassis Cardiac Surgery Center

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

The Role of TAVI in high-risk and normal-risk Patients

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Corrado Tamburino, MD, PhD

Transcatheter aortic valve replacement in intermediate and low risk patients-clinical evidence

TAVR for low-risk patients in 2017: not so fast.

Cardiac Valve/Structural Therapies

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

The Evolving ACC-NCDR Programs: What you need to know for your practice

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y.

Chronic Primary Mitral Regurgitation

Post-TAVI Cerebral Embolisms and Potential Protection Means

Aortic Valve Stenosis and TAVR: Putting it all together.

Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative

Is it Time for a National Network of Valve Centers? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC

Maurizio D Amico M.D.

Transcatheter aortic valve replacement (TAVR) has

Accepted Manuscript. Sixteen Years Later and the Debate for TAVR or SAVR Remains Controversial. Saina Attaran, MD, Vinod H.

Structural Heart Disease: Setting the Stage for Success

Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA

Anticoagulation. 2 Baylor College of Medicine

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA

In recent years, no field of clinical cardiology has experienced a

RANDOMISED TRIALS TAVI WITH SAVR STEPHAN WINDECKER AORTIC VALVE DISEASE COMPARING

The Future of TAVR: Minimalist Fast Track

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions

What is the Role of Surgical Repair in 2012

TAVR in 2020: What is Next!!!!

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

When to implant an ICD in systemic right ventricle?

Aortic valve implantation using the femoral and apical access: a single center experience.

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD

Mitral Valve Disease, When to Intervene

Subclinical Thrombosis of Bioprosthetic Aortic Valves: Is It Clinically Relevant? Tarun Chakravarty, MD

Transcription:

Published Manuscripts Based in the STS/ACC TVT Registry June 2018

Legend Manuscript Status is designated as follows: Abbreviations: Published/Full Citation Provided: Manuscript is in print. In Press: Manuscript accepted for publication but has not yet appeared in print or on-line. Am J Cardiol: American Journal of Cardiology Am J Emerg Med: American Journal of Emergency Medicine Am J Medicine: American Journal of Medicine Am Heart J: American Heart Journal Br Med J: British Medical Journal Catheter Cardiovasc Interv: Catheterization and Cardiovascular Interventions. Circulation: Circulation Circ Arrythm Electrophysiol: Circulation: Arrhythmia and Electrophysiology Circ Heart Fail: Circulation: Heart Failure Circ Interv: Circulation: Cardiovascular Interventions Circ Cardiovasc Imaging: Circulation: Cardiovascular Imaging Circulation: Cardiovasc Qual Outcomes: Circulation: Cardiovascular Quality and Outcomes Clin Cardiol: Clinical Cardiology Clin Med Res: Clinical Medicine and Research Eur Hear J: European Heart Journal Eur Hear J Quality Care Clinical Outcomes: European Heart Journal: Quality of Care & Clinical Outcomes Heart Rhythm: Heart Rhythm JACC: Journal of the American College of Cardiology JACC Cardiovasc Interv: Journal of the American College of Cardiology: Cardiovascular Interventions JACC Imaging: Journal of the American College of Cardiology: Cardiovascular Imaging JAHA: Journal of the American Heart Association JAMA: Journal of the American Medical Association JAMA Cardiol: Journal of the American Medical Association: Cardiology JAMA Int Med: Journal of the American Medical Association: Internal Medicine J Cardiovasc Manag: The Journal of Cardiovascular Management (Pub ended 2005) J Cardiovasc Electrophysiol: Journal of Cardiovascular Electrophysiology J Invas Cardiol: Journal of Invasive Cardiology Journal Biomed Inform: Journal of Biomedical Informatics J Cardiovasc. Manag: Journal of Cardiovascular Management NEJM: New England Journal of Medicine Pharmacoepidemiol Drug Saf: Pharmacoepidemiology and Drug Safety 2 P a g e

TVT Registry PUBLISHED 1. 8. Holmes DR, Brennan JM, Rumsfeld JS, et al. Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement. JAMA. 2015;313(10):1019-1028. 2. Editorial. Rumsfeld JS, Holmes DR, Stough WG, et al. Insights From the Early Experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. JACC Cardiovasc Interv. 2015;8(3):377-381. 3. Editorial. Mack MJ, Holmes DR. Rational Dispersion for the Introduction of Transcatheter Valve Therapy. JAMA. 2011;306(19):2149-2150. 4. Editorial. Carroll JD, Shuren J, Jensen ST, et al. Transcatheter Valve Therapy Registry Is a Model for Medical Device Innovation and Surveillance. Health Affairs. 2015;34(2):328-334. 5. 05T/3. Brennan JM, Holmes DR, Sherwood MW, et al. The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States. Annals of Thoracic Surgery. 2014;98(6):2016-22 6. Editorial. Carroll JD, Edwards FH, Marinac-Dabic D, et al. The STS-ACC Transcatheter Valve Therapy National Registry: A New Partnership and Infrastructure for the Introduction and Surveillance of Medical Devices and Therapies. JACC. 2013;62(11):1026-1034. 7. 04T/2. Mack MJ, Brennan JM, Brindis R. Outcomes Following Transcatheter Aortic Valve Replacement in the United States. JAMA. 2013;310(19):2069-2077. 8. Editorial. Sedrakyan A, Marinac-Dabic D, Holmes DR. The international registry infrastructure for cardiovascular device evaluation and surveillance. JAMA. 2013;310(3):257-9 9. 44/50T. Thourani VH, Jensen HA, Babaliaros V, et al. Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. Annals of Thoracic Surgery. 2015;100:1718 27. 10. 74 /25T. Suri RM, Gulack BC, Brennan JM, et al. Outcomes of Patients with Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement. Annals of Thoracic Surgery. Available online 29 August 2015. 11. 107. Holmes DR, Nishimura RA, Grover FL, et al. Annual Outcomes with Transcatheter Valve Therapy: From the STS/ACC TVT Registry. Annals of Thoracic Surgery. 2016;101(2):789-800. 12. 33. Arnold SV, Spertus JA, Vemulapalli S, et al. Association of Patient-Reported Health Status with Long- June 2018 Page 3

Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry. Circ Interv. 2015;8(12). 13. 109. Sorajja P, Mack M, Vemulapalli S, et al. Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States. JACC. 2016; 67(10). 14. 108. Edwards FH, Cohen DJ, O Brien SM, et al. Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2016;1(1):46-52. 15. 72. Arsalan M, Szerlip M, Vemulapalli S, et al. Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians? Insights From the STS/ACC TVT Registry. JACC. 2016;67(10). 16. 27. Alfredsson J, Stebbins A, Brennan JM, et al. Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement: Results from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation. 2016;133. 17. 37. Baron SJ, Arnold SV, Herrmann HC, et al. Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement. JACC. 2016;67(20):2349-2358. 18. 5. O Brien SM, Cohen DJ, Rumsfeld JS, et al. Variation in Hospital Risk-Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States: A Report from the STS/ACC TVT Registry. Circ Cardiovasc Qual Outcomes. 2016;9:560-565. 19. 105. Fadahunsi OA, Olowoyeye A, Ukaigwe A, et al. Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis from STS/ACC TVT Registry. JACC Cardiovasc Interv. 2016;9(21):2189-2199. 20. 90. Chandrasekhar J, Dangas G, Yu J, et al. Sex-Based Differences in Outcomes with Transcatheter Aortic Valve Therapy. JACC. 2016;68(25);2733-44. 21. 169. Arnold SV, Spertus JA, Vemulapalli S, et al. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report from the STS/ACC TVT Registry. JAMA Cardiol. 2017;2(4):409-416. 22. 130. Dodson JA, Williams MR, Cohen DJ, et al. Home Practice of Direct-Home Discharge and 30-Day Readmission After Transcatheter Aortic Valve Replacement in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) Registry. JAHA. 2017;6(8). 23. 34. Hira RS, Vemulapalli S, Li Z, et al. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement Insights from the NCDR STS/ACC TVT Registry. JAMA Cardiol. 2017;2(8):846-854. 24. 106. Carroll JD, Vemulapalli S, Dai D, et al. Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes. JACC. 2017;70(1). 25. 269. Brennan MJ, Thomas L, Cohen DJ, et al. Transcatheter Versus Surgical Aortic Valve Replacement. JACC. 2017;70(4). June 2018 Page 4

26. 245. Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes with Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report. JACC. 2017;70(19):2315-2327. 27. 119. Hyman MC, Vemulapalli S, Szeto WY, et al. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the NDCR STS/ACC TVT Registry. Circulation. 2017;136(22). 28. 42. Mavromatis K, Thourani VH, Stebbins A, et al. Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis and Mitral Regurgitation. Annals of Thoracic Surgery. 2017;104(6). 29. 243. Sorajja P, Kodali S, Reardon MJ, et al. Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2017;10(20):2090-2098. 30. 190. Fanaroff AC, Manandhar P, Holmes DR, et al. Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes. Circ Interv. 2017;10(10). 31. 174. Abramowitz Y, Vemulapalli S, Chakravarty T, et al. Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights from the STS/ACC TVT Registry. Circ Interv. 2017;10(11). 32. 180. Hansen, JW, Foy, A, Yadav, P, et al. Death and Dialysis After Transcatheter Aortic Valve Replacement. An Analysis of the STS/ACC TVT Registry. JACC Cardiovasc Interv. Sept. 2017 33. 254. Kolte, D., Khera, S., Vemulapalli, S. Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights from the STS/ACC TVT Registry. JACC. March 2018 34. 140. McCarthy, FH, Vemulapalli, S, Zhuokai, L, et al. The Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. ATS. March 2018 35. 153. Joseph, L, Bashir, M, Xiang, Q, et al. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry. JACC Cardiovasc Interv. April 2018 IN PRESS 1. 58. Tuzcu, M. et al. 30 Day and 1 year Outcome of Valve-in-Valve (ViV) TAVR. JACC 2018. 2. 7. Sherwood, M. et al. Practice patterns and outcomes associated with differential use of antithrombotics after TAVR: Insights from the STS/ACC TVT Registry. AHJ 2018 3. 155. Velmulpalli, S et al. Post-Procedure Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: Incidence, Management, and Outcomes Insights from the STS/ACC TVT Registry. JACC: CI 2018 June 2018 Page 5

4. 191. Jones, WS, et al. Stroke and Transient Ischemic Attack Among Patients with Extracranial Carotid Artery Disease Undergoing Transcatheter Aortic Valve Replacement. Circ Interv 2018 June 2018 Page 6